Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruxana Sadikot

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
American Journal of Respiratory and Critical Care Medicine|April 15, 2017
What is Bronchiectasis?Colin Swenson, Dean Schraufnagel, Ruxana Sadikot
American Journal of Respiratory and Critical Care Medicine|November 16, 2017
Treating BronchiectasisColin Swenson, Dean Schraufnagel, Ruxana Sadikot
Biomed Research International|April 17, 2015
The role of lipids mediators in inflammation and resolutionAlexandre de Paula Rogerio, Carlos Artério Sorgi, Ruxana Sadikot, et al.
Biomed Research International|July 11, 2015
Nontuberculous Mycobacteria: Epidemiologic, Mycobacteriologic, and Clinical AspectsMehdi Mirsaeidi, Parissa Farnia, Ruxana Sadikot, et al.
Plos One|September 29, 2017
Body habitus in patients with and without bronchiectasis and non-tuberculous mycobacteriaMichael D Schweitzer, Oriana Salamo, Michael Campos, et al.
Stem Cells International|June 14, 2019
Mesenchymal Stem Cell-Based Therapy of Inflammatory Lung Diseases: Current Understanding and Future PerspectivesC Randall Harrell, Ruxana Sadikot, Jose Pascual, et al.
Analytical Cellular Pathology (Amsterdam)|April 8, 2020
Molecular and Cellular Mechanisms Responsible for Beneficial Effects of Mesenchymal Stem Cell-Derived Product "Exo-d-MAPPS" in Attenuation of Chronic Airway InflammationCarl Randall Harrell, Dragica Miloradovic, Ruxana Sadikot, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 18, 2013
Conditional deletion of FAK in mice endothelium disrupts lung vascular barrier function due to destabilization of RhoA and Rac1 activitiesTracy Thennes Schmidt, Mohammad Tauseef, Lili Yue, et al.
Mediators of Inflammation|July 3, 2013
Celecoxib improves host defense through prostaglandin inhibition during Histoplasma capsulatum infectionPriscilla Aparecida Tartari Pereira, Bruno Caetano Trindade, Adriana Secatto, et al.
American Journal of Respiratory and Critical Care Medicine|August 31, 2010
Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort studyOgnjen Gajic, Ousama Dabbagh, Pauline K Park, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
American Journal of Respiratory and Critical Care Medicine|April 15, 2017
What is Bronchiectasis?Colin Swenson, Dean Schraufnagel, Ruxana Sadikot
American Journal of Respiratory and Critical Care Medicine|November 16, 2017
Treating BronchiectasisColin Swenson, Dean Schraufnagel, Ruxana Sadikot
Biomed Research International|April 17, 2015
The role of lipids mediators in inflammation and resolutionAlexandre de Paula Rogerio, Carlos Artério Sorgi, Ruxana Sadikot, et al.
Biomed Research International|July 11, 2015
Nontuberculous Mycobacteria: Epidemiologic, Mycobacteriologic, and Clinical AspectsMehdi Mirsaeidi, Parissa Farnia, Ruxana Sadikot, et al.
Plos One|September 29, 2017
Body habitus in patients with and without bronchiectasis and non-tuberculous mycobacteriaMichael D Schweitzer, Oriana Salamo, Michael Campos, et al.
Stem Cells International|June 14, 2019
Mesenchymal Stem Cell-Based Therapy of Inflammatory Lung Diseases: Current Understanding and Future PerspectivesC Randall Harrell, Ruxana Sadikot, Jose Pascual, et al.
Analytical Cellular Pathology (Amsterdam)|April 8, 2020
Molecular and Cellular Mechanisms Responsible for Beneficial Effects of Mesenchymal Stem Cell-Derived Product "Exo-d-MAPPS" in Attenuation of Chronic Airway InflammationCarl Randall Harrell, Dragica Miloradovic, Ruxana Sadikot, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 18, 2013
Conditional deletion of FAK in mice endothelium disrupts lung vascular barrier function due to destabilization of RhoA and Rac1 activitiesTracy Thennes Schmidt, Mohammad Tauseef, Lili Yue, et al.
Mediators of Inflammation|July 3, 2013
Celecoxib improves host defense through prostaglandin inhibition during Histoplasma capsulatum infectionPriscilla Aparecida Tartari Pereira, Bruno Caetano Trindade, Adriana Secatto, et al.
American Journal of Respiratory and Critical Care Medicine|August 31, 2010
Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort studyOgnjen Gajic, Ousama Dabbagh, Pauline K Park, et al.
Pageof 1